Richard S. Shames, Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 1,512 shares at $17.00 ($26K) on 2017-08-29, disclosed to the SEC on 2017-08-30.
Scheduled sale ($26k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2017-12-27 | $145K | — | Filing → |
| PTGX | SELL | 2017-10-10 | $38K | — | Filing → |
| PTGX | SELL | 2017-09-12 | $106K | — | Filing → |